Overview
Lymphocyte and Cytokine Disturbances in Polymyalgia Rheumatica
Status:
Completed
Completed
Trial end date:
2015-06-01
2015-06-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Pathophysiology of polymyalgia rheumatica (PMR) is ill defined. This study aims at characterizing immunological abnormalities in PMR patients, and to assess the effects of tocilizumab therapy on this abnormalities.Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
University Hospital, Brest
Criteria
Inclusion Criteria:- PMR patient included in the TENOR study with samples available
Exclusion Criteria:
- Patient not included in the TENOR study